Regeneron Pharmaceuticals Files 2024 10-K
Ticker: REGN · Form: 10-K · Filed: 2025-02-05T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Regeneron dropped its 2024 10-K. All systems go.
AI Summary
Regeneron Pharmaceuticals, Inc. filed its 2024 10-K on February 5, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered at 777 Old Saw Mill River Road in Tarrytown, NY, operates within the pharmaceutical preparations industry. Key financial and operational details for the fiscal year are presented in this comprehensive annual report.
Why It Matters
This filing provides investors and the public with a detailed overview of Regeneron's financial performance, strategic initiatives, and risk factors for the 2024 fiscal year, crucial for understanding the company's current standing and future outlook.
Risk Assessment
Risk Level: low — This is a standard annual financial filing (10-K) and does not inherently present new risks beyond those typically associated with a publicly traded pharmaceutical company.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 1231 — Fiscal Year End (Indicates the end date of the reporting period)
Key Players & Entities
- REGENERON PHARMACEUTICALS, INC. (company) — Filer
- 0000872589 (company) — Central Index Key
- 20241231 (date) — Conformed Period of Report
- 20250205 (date) — Filed as of Date
- 777 OLD SAW MILL RIVER ROAD (address) — Business Address
- TARRYTOWN (location) — City
- NY (location) — State
- 10591 (postal_code) — ZIP Code
- 9148477000 (phone_number) — Business Phone
- KathrynGuariniPh.D.Membe (person) — Mentioned in filing context
FAQ
What is Regeneron's primary industry classification?
Regeneron Pharmaceuticals, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
When was this 10-K filing submitted to the SEC?
The filing was submitted on February 5, 2025.
What is the company's main business address?
The business address is 777 Old Saw Mill River Road, Tarrytown, NY 10591.
What is the Central Index Key (CIK) for Regeneron Pharmaceuticals, Inc.?
The Central Index Key for Regeneron is 0000872589.
What is the SEC file number for this company?
The SEC file number for Regeneron Pharmaceuticals, Inc. is 000-19034.
From the Filing
0001804220-25-000011.txt : 20250205 0001804220-25-000011.hdr.sgml : 20250205 20250205091814 ACCESSION NUMBER: 0001804220-25-000011 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 127 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250205 DATE AS OF CHANGE: 20250205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 25591109 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 10-K 1 regn-20241231.htm 10-K regn-20241231 0000872589 2024 FY false 378 http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent iso4217:USD xbrli:shares iso4217:USD xbrli:shares regn:segment xbrli:pure regn:milestone regn:vote regn:claim regn:complaint 0000872589 2024-01-01 2024-12-31 0000872589 2024-06-28 0000872589 us-gaap:CommonClassAMember 2025-01-23 0000872589 us-gaap:CommonStockMember 2025-01-23 0000872589 2024-10-01 2024-12-31 0000872589 regn:KathrynGuariniPh.D.Member 2024-10-01 2024-12-31 0000872589 regn:KathrynGuariniPh.D.Member 2024-12-31 0000872589 2024-12-31 0000872589 2023-12-31 0000872589 us-gaap:CommonClassAMember 2023-12-31 0000872589 us-gaap:CommonClassAMember 2024-12-31 0000872589 us-gaap:CommonStockMember 2023-12-31 0000872589 us-gaap:CommonStockMember 2024-12-31 0000872589 us-gaap:ProductMember 2024-01-01 2024-12-31 0000872589 us-gaap:ProductMember 2023-01-01 2023-12-31 0000872589 us-gaap:ProductMember 2022-01-01 2022-12-31 0000872589 regn:CollaborationRevenueMember 2024-01-01 2024-12-31 0000872589 regn:CollaborationRevenueMember 2023-01-01 2023-12-31 0000872589 regn:CollaborationRevenueMember 2022-01-01 2022-12-31 0000872589 us-gaap:ProductAndServiceOtherMember 2024-01-01 2024-12-31 0000872589 us-gaap:ProductAndServiceOtherMember 2023-01-01 2023-12-31 0000872589 us-gaap:ProductAndServiceOtherMember 2022-01-01 2022-12-31 0000872589 2023-01-01 2023-12-31 0000872589 2022-01-01 2022-12-31 0000872589 regn:CollaborationandContractManufacturingMember 2024-01-01 2024-12-31 0000872589 regn:CollaborationandContractManufacturingMember 2023-01-01 2023-12-31 0000872589 regn:CollaborationandContractManufacturingMember 2022-01-01 2022-12-31 0000872589 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-12-31 0000872589 us-gaap:CommonStockMember 2021-12-31 0000872589 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000872589 us-gaap:RetainedEarningsMember 2021-12-31 0000872589 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000872589 us-gaap:TreasuryStockCommonMember 2021-12-31 0000872589 2021-12-31 0000872589 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000872589 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000872589 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0000872589 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000872589 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000872589 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-3